John Hinze, DO
Critical Care Medicine · Austin, TXNPI 1013933019
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (37.6%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. 21 manufacturers reported payments, led by Intuitive Surgical at 51.0% of the total. Reporting peaked in 2024 at $8,038 and has fallen 97.3% since, to $217 in 2025. Among critical care medicine clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 136 payments — averaging $208.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$14K
- Ambu Inc.$6K
- Pfizer$3K
- Pulmonx Corporation$2K
- Conmed Corporation$1K
- E.r. Squibb & Sons, L.L.C.$500
- plus $2K from 15 others
What the payments were for
- Consulting fees$7,57527%
- Speaking & faculty fees$10,67538%
- Travel & lodging$3,50812%
- Food & beverage$3,59613%
- Education$3,00011%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 21 | $14,458 |
| Ambu Inc. | 4 | $6,075 |
| Pfizer | 3 | $2,833 |
| Pulmonx Corporation | 15 | $1,708 |
| Conmed Corporation | 1 | $1,000 |
| E.r. Squibb & Sons, L.L.C. | 1 | $500 |
| Covidien LP | 4 | $251 |
| Actelion Pharmaceuticals US, Inc. | 18 | $244 |
| GSK | 17 | $210 |
| AstraZeneca(2 entities) | 10 | $193 |
| Boehringer Ingelheim | 9 | $162 |
| Sunovion Pharmaceuticals Inc. | 12 | $145 |
| Olympus America Inc. | 2 | $128 |
| Steris Corporation | 1 | $89 |
| Mylan Specialty L.p. | 6 | $77 |
| Philips North America LLC | 3 | $68 |
| Medtronic | 1 | $68 |
| Sanofi | 4 | $65 |
| Genentech USA, Inc. | 2 | $41 |
| Regeneron Healthcare Solutions, Inc. | 1 | $26 |
| Johnson & Johnson | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$7,182
- DA VINCI SP$4,150
- ELIQUIS$3,333
- ION$3,000
- Pulmonx Endobronchial Valve EBV$1,148
- CONMED BIOPSY$1,000
- superDimension$149
- CHARTIS CATHETER$125
- ZEPHYR DELIVERY CATHETER$125
- ZEPHYR ENDOBRONCHIAL VALVE$125
- PULMONX CHARTIS TABLET CONSOLE$125
How this compares
$28,353 in reported general payments places this provider in the 95th percentile of 507 critical care medicine providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other critical care medicine in Austin
- William BartekAustin$284K
- Subramaniyam RajanAustin$98K
- Matthew AndersonAustin$79K
- Steven DavidoffPlano$364K
- Edwin ParsleyHouston$283K
- Hector PayanEl Paso$245K
- Bindu AkkantiHouston$185K
- Faisal MasudHouston$155K
- Sergio Trevino CastilloHouston$133K
- Akinyinka AjelabiKingwood$109K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.